Aardvark Therapeutics, Inc. announced key leadership appointments to enhance its team as it progresses with its Phase 3 HERO study of ARD-101 for treating hyperphagia associated with Prader-Willi ...
SAN DIEGO, May 19, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate ...
Timothy Kieffer, Ph.D., appointed Chief Scientific Officer Danny Villeneuve appointed Chief Commercial Officer Terrie Kellmeyer, Ph.D., appointed Senior Vice President, Regulatory Affairs Christian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results